title: Stable bone mineral density in lumbar spine and hip in contrast to bone loss in the hands during long-term treatment with infliximab in patients with rheumatoid arthritis.
authors.forename: Danielle A
authors.initials: DA
authors.lastname: Eekman
authors.forename: Marijn
authors.initials: M
authors.lastname: Vis
authors.forename: Irene E M
authors.initials: IE
authors.lastname: Bultink
authors.forename: Dirk J
authors.initials: DJ
authors.lastname: Kuik
authors.forename: Alexandre E
authors.initials: AE
authors.lastname: Voskuyl
authors.forename: Ben A C
authors.initials: BA
authors.lastname: Dijkmans
authors.forename: Willem F
authors.initials: WF
authors.lastname: Lems
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000503:physiopathology; D015519:Bone Density / Q000187:drug effects*; D005260:Female; D050823:Hand Joints / Q000503:physiopathology; D006621:Hip Joint / Q000503:physiopathology; D006801:Humans; D000069285:Infliximab; D008159:Lumbar Vertebrae / Q000503:physiopathology; D008297:Male; D008875:Middle Aged
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab